If you are searching the internet for "bloodborne pathogens" you may already know and understand what they are. However, many people may not.
A bloodborne pathogen is a disease producing bacteria or microorganism. OSHA defines a bloodborne pathogen as a pathogenic microorganism present in human blood that can lead to disease. There are many disease carrying pathogenic microorganisms that are covered by OSHA's Bloodborne Pathogen Standard (29 CFR 1910.1030); however, the most common and those of primary concern are Human Immunodeficiency Virus (HIV), Hepatitis B (HBV), and Hepatitis C (HCV).
Human Immunodeficiency Virus (HIV):
- HIV is the virus that leads to acquired immunodeficiency syndrome (AIDS). A person can carry HIV for many years and not have symptoms until it turns into full-blown AIDS.
- AIDS attacks the person’s immune system, which makes it difficult for the body to fight off disease.
- Scientists and medical authorities agree that HIV does not survive well outside the body. Drying of HIV-infected human blood or other body fluids reduces the risk of environmental transmission to essentially zero.
- HIV is found in very low quantities in saliva and tears from some AIDS patients. HIV has not been found in the sweat of HIV-infected persons. Contact with saliva, tears, or sweat has never been shown to result in the transmission of HIV.
Hepatitis B Virus (HBV):
- 1 to 1 ¼ million Americans are chronically infected
- Symptoms include: jaundice, fatigue, abdominal pain, loss of appetite, intermittent nausea, vomiting
- May lead to chronic liver disease, liver cancer, and death
- Vaccination available since 1982
- HBV can survive for at least one week in
dried blood
Hepatitis C Virus (HCV):
- An estimated 3.9 million Americans have been infected with HCV of whom 2.7 million are chronically infected.
- Persons chronically infected with HCV may not be aware of it because they are not clinically ill. Sometimes it can take two decades before symptoms are recognized.
- Chronic liver disease occurs in approximately 70 percent of infected persons.
- There are some drugs that have been licensed for treatment of HCV; however, they are only effective in 10-40 percent of persons.
- 8,000-10,000 deaths occur each year as a result of the chronic liver disease.
- There are some drugs that have been licensed for treatment of HCV; however, they are only effective in 10-40 percent of persons.
0 comments:
Post a Comment